Publication | Closed Access

The natural product bergenin ameliorates lipopolysaccharide-induced acute lung injury by inhibiting NF-kappaB activition

Acute Lung InjuryInflammationNatural Product BergeninCytokineAnti-inflammatoryInflammatory Lung DiseaseLung InflammationMedicineRespiratory ToxicologyImmunologyCell DeathPulmonary PharmacologyPulmonary FibrosisPharmacologyNf-kappab ActivitionOxidative Stress